Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Bio-Rad Laboratories, Inc.

Market Cap 7.89B 6.84B 6.31B 5.91B 11.04B 755B 11.27B 75.24B 29.13B 364B 29.6B 28.96B 1,265B P/E Ratio 2026 *
35.1x
P/E Ratio 2027 * 34.4x
Enterprise Value 7.14B 6.19B 5.71B 5.35B 9.99B 683B 10.2B 68.1B 26.36B 329B 26.79B 26.21B 1,145B EV / Sales 2026 *
2.78x
EV / Sales 2027 * 2.63x
Free-Float
60.28%
Yield 2026 *
-
Yield 2027 * -
1 day+0.49%
1 week-4.89%
Current month-6.41%
1 month+19.96%
3 months+8.36%
6 months-6.86%
Current year-3.48%
1 week 287.73
Extreme 287.73
298.58
1 month 236.73
Extreme 236.73
319.86
Current year 236.73
Extreme 236.73
328.56
1 year 222.8
Extreme 222.8
343.12
3 years 211.43
Extreme 211.43
431.79
5 years 211.43
Extreme 211.43
832.7
10 years 135.94
Extreme 135.94
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 65 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap.
05-10Sell

Executive/Senior Manager

-550 0.0025%
04-23Fiscal year

General Counsel

449 0.0020%
04-23Fiscal year

Chief Financial Officer

2,576 0.0117%
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%-4.89%+27.04%-19.00% 7.85B
+0.54%-1.24%-33.73%-11.84% 155B
+0.10%-1.95%-8.78%-4.06% 103B
+0.09%+4.13%-1.80%+57.94% 54.72B
+1.62%-1.10%+53.10%+49.41% 53.65B
-0.30%-1.48%-14.69%-41.41% 40.72B
+1.61%+7.78% - - 30.9B
+0.64%+3.66%-9.33%-39.48% 28.85B
-0.18%+4.10%+47.47%-5.15% 23.38B
-1.70%-2.28%-15.89%-0.22% 21.22B
Average +0.30%+0.80%+4.82%-1.53% 51.97B
Weighted average by Cap. +0.39%+0.01%-6.70%+0.95%

Financials

2026 *2027 *
Net sales 2.57B 2.23B 2.05B 1.92B 3.6B 246B 3.67B 24.5B 9.48B 118B 9.64B 9.43B 412B 2.63B 2.29B 2.11B 1.97B 3.69B 252B 3.77B 25.14B 9.73B 122B 9.89B 9.68B 423B
Net income 225M 195M 180M 169M 315M 21.53B 321M 2.15B 831M 10.38B 844M 826M 36.08B 230M 199M 184M 172M 322M 22B 328M 2.19B 849M 10.6B 862M 844M 36.87B
Net Debt -749M -650M -599M -561M -1.05B -71.72B -1.07B -7.15B -2.77B -34.57B -2.81B -2.75B -120B -965M -838M -772M -724M -1.35B -92.44B -1.38B -9.21B -3.57B -44.56B -3.62B -3.55B -155B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-06-11 292.44 $ +0.49% 370,658
26-06-10 291.01 $ -2.07% 370,809
26-06-09 297.17 $ +2.01% 437,001
26-06-08 291.31 $ -1.02% 430,962
26-06-05 294.32 $ -4.28% 346,902
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
292.44USD
Average target price
297.00USD
Spread / Average Target
+1.56%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!